Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Neos Therapeutics (NEOS)

8.2 0 (0%)

04-20 16:00

Open:

8.15

Pre. Close:

8.2

High:

8.4

Low:

8.15

Volume:

90,140

Market Cap:

238M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.404 - 8.446

8.446 - 8.488

Low:

8.053 - 8.096

8.096 - 8.139

Close:

8.132 - 8.199

8.199 - 8.267

Technical analysis  (as of: 2018-04-20 4:32:06 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 10.17     One year: 10.75

Support:

Support1: 7.90    Support2: 6.57

Resistance:

Resistance1: 8.70    Resistance2: 9.20

Pivot:

8.33

Moving Averages:

MA(5): 8.35     MA(20): 8.35

MA(100): 9.43     MA(250): 8.64

MACD:

MACD(12,26): -0.13     Signal(12,26,9): -0.15

%K %D:

%K(14,3): 53.33     %D(3): 61.62

RSI:

RSI(14): 41.82

52-Week:

High: 13.15  Low: 6.3  Change(%): 15.5

Average Vol(K):

3-Month: 28687  10-Days 13938

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NEOS has closed above bottom band by 22.4%. Bollinger Bands are 66% narrower than normal. The narrow width of the bands suggests low volatility as compared to NEOS's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-03-19T11:42:46-04:00
Biotech Forum Daily Digest For March 19th

2018-03-15T12:05:50-04:00
Neos Therapeutics' (NEOS) CEO Vipin Garg on Q4 2017 Results - Earnings Call Transcript

2018-03-15T08:30:09-04:00
Neos Therapeutics revenues up 126% in Q4

2018-03-15T07:01:26-04:00
Neos Therapeutics beats by $0.11, misses on revenue

2018-02-20T09:56:00-05:00
Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities

2018-02-20T07:00:00-05:00
PDL BioPharma Terminates Interest in Pursuing Acquisition of Neos

2018-01-31T08:04:47-05:00
Premarket analyst action - healthcare

2018-01-23T08:51:47-05:00
Neos Therapeutics: Cotempla Off To A Strong Start

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

29.00

Shares Float (M)

27.13

% Held by Insiders

6.40

% Held by Institutions

50.40

Shares Short (K)

2851

Shares Short Prior Month (K)

2560

Stock Financials

EPS

-2.770

EPS Est. Current Year

-3.110

EPS Est. Next Year

-1.440

EPS Est. Next Quarter

-0.670

Forward EPS

-0.010

Book Value (p.s.)

30.140

PEG Ratio

-0.14

Profit Margin

Operating Margin

-227.90

Return on Assets (ttm)

-70.7

Return on Equity (ttm)

-2089.1

Qtrly Rev. Growth

122.3

Gross Profit (p.s.)

0.263

Sales Per Share

EBITDA (p.s.)

-1.469

Qtrly Earnings Growth

Operating Cash Flow (M)

-53.26

Levered Free Cash Flow (M)

-33.16

atoplab.com

Valuation

P/E

-2.96

P/E Growth Ratio

P/BV

0.27

P/S

235445536.00

P/CF

-4.46

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.